Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University, College of Medicine, Seoul, Republic of Korea
Auto-generated profile, based on publicly available information
Hyunsik Jang
Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University, College of Medicine, Seoul, Republic of Korea
The goal of this study was to evaluate the clinicopathological and imaging features of thyroid nodules surgically diagnosed as hyaline trabecular tumor (HTT), and to assess the role of cytology and frozen sections (FS) in the diagnosis of HTT. This study included 21 thyroid nodules in 21 patients treated from August 2005 to March 2015 (mean age, 53.3 years) who were either diagnosed as HTT or had HTT suggested as a possible diagnosis based on cytology, FS, or the final pathology report. Patients' medical records were retrospectively reviewed for cytopathologic results and outcomes during the course of follow-up. Sonograms were reviewed and categorized. Twelve nodules from 12 patients were surgically confirmed as HTT. Ultrasonography (US)-guided fine needle aspiration (FNA) was performed on 11 nodules, of which six (54.5%) were papillary thyroid carcinoma (PTC) or suspicious for PTC and three (27.3%) were HTT or suspicious for HTT. Intraoperative FS suggested the possibility of HTT in seven nodules, of which four (57.1%) were confirmed as HTT. US-FNA suggested the diagnosis of HTT in 10 nodules, of which three (30.0%) were confirmed as HTT. Common US features of the 12 pathologically confirmed cases of HTT were hypoechogenicity or marked hypoechogenicity (83.4%), absence of calcifications (91.7%), parallel shape (100.0%), presence of vascularity (75.0%), and probable benignity (58.3%). HTT should be included in the differential diagnosis of solid tumors with hypoechogenicity or marked hypoechogenicity and otherwise benign US features that have been diagnosed as PTC through cytology.
Although the bismuth breast shield can reduce radiation exposure to the breast during dual-energy computed tomography (DECT), it can potentially affect material quantification on DECT due to artifacts. To evaluate the effects of bismuth breast shielding on iodine quantification and radiation exposure in DECT. Small balloons were made with 0.2%, 0.6% and 1.0% blended iodinated contrast (370 mg/mL of iodine) with water. The balloons were located at both anterior and posterior lungs in an adult anthropomorphic chest phantom. DECT was performed with and without breast shielding. Afterwards, iodine concentration values were measured for each balloon on the iodine maps. Absorbed radiation doses in the breast were measured with the optically stimulated luminescence dosimeter. After shielding, we obtained significantly decreased iodine quantification for all three concentrations with 0.78 ± 0.13 to 0.46 ± 0.13 mg/mL, 2.31 ± 0.17 to 1.68 ± 0.19 mg/mL, and 3.82 ± 0.10 to 2.84 ± 0.20 mg/mL at the anterior location, and 0.72 ± 0.11 to 0.48 ± 0.09 mg/mL, 2.24 ± 0.13 to 1.87 ± 0.21 mg/mL, and 3.75 ± 0.16 to 3.15 ± 0.14 mg/mL at the posterior location for the 0.2%, 0.6%, and 1.0% balloons, respectively (P = 0.001 for all). After shielding, absorbed radiation doses to the breast significantly decreased by 14.8% (4.32 ± 0.33 to 3.68 ± 0.30 mGy; P = 0.005). Although using the bismuth breast shield may decrease radiation exposure to the breast on DECT, it may also significantly affect iodine quantification.